ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025
SERS-AI-LUA-Driven Salivary Diagnosis of Head and Neck Cancer Using Graphene-Assisted Plasmonic Nanocorals.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- SERS-AI-LUA-Driven Salivary Diagnosis of Head and Neck Cancer Using Graphene-Assisted Plasmonic Nanocorals.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
The early detection of head and neck cancer (HNC) remains an important challenge owing to the lack of reliable noninvasive biomarkers. This study introduces a graphene-assisted plasmonic nanocoral platform coupled with an artificial intelligence-linear unmixing algorithm for diagnosing HNC from saliva and identifying associated metabolic biomarkers. The nanocoral structures, formed via a spontaneous gold growth mechanism on graphene templates, exhibit strong plasmonic enhancement and selective adsorption of volatile metabolites. Raman signals acquired from the saliva of HNC patients and healthy individuals are analyzed using a logistic regression model, achieving 98% classification accuracy. To identify potential metabolic biomarkers, candidate metabolites are initially selected based on spectral similarity using the Pearson correlation coefficient. Subsequently, the nonnegative least squares method is applied to refine this selection and extract the final set of biomarker candidates. This approach identifies 15 potential metabolic biomarkers, and their clinical relevance is corroborated through comparison with the findings of previous clinical studies. This study not only introduces a highly sensitive, noninvasive diagnostic platform for HNC but also establishes a robust framework for Raman-based biomarker discovery, with potential applicability that warrants evaluation in other biofluid-based disease models in future studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.